N-glycan profile of anti-α-Gal antibodies. PNGase F-released N

Highly sensitive characterization of non-human glycan structures of monoclonal antibody drugs utilizing tandem mass spectrometry

Lyme Disease IgG N-linked Glycans Contrast the Canonical Inflammatory Signature

PDF) Purification and Characterization of Antibodies Directed against the α-Gal Epitope

Complete spatial characterisation of N-glycosylation upon striatal neuroinflammation in the rodent brain, Journal of Neuroinflammation

Complete spatial characterisation of N-glycosylation upon striatal neuroinflammation in the rodent brain, Journal of Neuroinflammation

N-glycan profile of anti-α-Gal antibodies. PNGase F-released N-glycans

RP-Amide HPLC of mosquito neutral N-glycans: The pyridylaminated

Full article: Galactosylation variations in marketed therapeutic antibodies

Digests of PNGase A-released glycans from the f ut-6;f ut-8 mutant. (A

The restricted nature of protein glycosylation in the mammalian brain

BioChem, Free Full-Text

N-glycan profile of anti-α-Gal antibodies. PNGase F-released N-glycans

Small RNAs are modified with N-glycans and displayed on the surface of living cells - ScienceDirect

Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro - ScienceDirect

High-throughput N-glycan screening method for therapeutic antibodies using a microchip-based DNA analyzer: a promising methodology for monitoring monoclonal antibody N-glycosylation